LASIK is often the first procedure people think of when they want to reduce dependence on glasses or contacts. It is familiar, widely discussed, and easy to search. But a LASIK consultation does not always end with a LASIK recommendation.
That can surprise patients. Some assume the main question is whether their prescription can be treated. In reality, refractive surgery planning is more specific than that. The clinical team is looking at the shape of the cornea, how much tissue is available, whether the eyes are dry, how stable the prescription has been, and whether another option may be safer or more predictable.
Amjad Khokhar, M.D., F.A.A.O., from Houston LASIK & Eye, explains that the right vision correction procedure depends on the structure and health of the individual eye, not just the patient’s interest in one procedure name. For some people, PRK or EVO ICL may be a better fit than LASIK because these options solve the vision problem in a different way.
That does not make either option a fallback. It means the procedure should be chosen based on the eye’s measurements, health, and long-term needs.
Table of Contents
Corneal thickness can limit LASIK options
LASIK and PRK both reshape the cornea, which is the clear front surface of the eye. The FDA explains that LASIK changes the eye’s focusing power by removing corneal tissue with a laser, while PRK also reshapes the cornea but exposes the treatment layer differently [1].
The difference matters because LASIK involves creating a flap in the cornea before the laser reshapes tissue underneath. After the laser treatment, the flap is placed back into position. For many good candidates, this approach can offer a convenient recovery profile. But the surgeon still has to calculate how much corneal tissue will remain after the flap and laser correction.
That is where corneal thickness becomes important.
If the cornea is thinner or if the prescription would require removing more tissue, LASIK may not be the strongest option. The FDA’s LASIK checklist specifically lists corneal thickness as a factor patients should understand before surgery [2]. Its patient guidance also warns that performing a refractive procedure on a cornea that is too thin may lead to serious complications [3].
PRK can be useful in some of these conversations because it does not require a LASIK flap. The laser still reshapes the cornea, and the eye still needs enough tissue for safe treatment. A 2025 systematic review and meta-analysis in the Journal of Cataract & Refractive Surgery found encouraging safety and efficacy results for PRK and transepithelial PRK in selected patients with thin corneas, no other ocular pathology, and normal topography. The authors also noted that the available evidence relied on case-series data and that stronger long-term studies are still needed [4].
This is why a person cannot reliably decide between LASIK and PRK from a prescription alone. Two patients may both be nearsighted. One may have thick, regular corneas and a prescription that fits well within LASIK planning. Another may have thinner corneas or a higher correction that makes PRK worth a closer look.
An eye chart is only part of the evaluation. Corneal mapping can change the recommendation.
Dry eye and contact lens intolerance deserve attention
Dry eye can be easy to dismiss until it starts shaping the day. Contacts feel fine in the morning, then scratchy by midafternoon. Vision comes and goes during laptop work. Eye drops become part of the desk setup. Night driving feels less crisp than it used to.
For refractive surgery planning, those details matter.
The FDA checklist asks patients to consider tear production before LASIK and warns that dry eyes may worsen or develop after surgery [2]. FDA guidance also says LASIK tends to aggravate dry eye [3]. That does not mean every person with dry eye is automatically excluded from LASIK, but it does mean dryness should be measured and managed before anyone rushes into a surgical plan.
Contact lens intolerance is another clue. Some people want vision correction because contacts are annoying or inconvenient. Others want it because their eyes can barely tolerate lenses anymore. Those are different situations.
If a patient’s main problem is dryness, irritation, or fluctuating vision, the provider may need to treat the ocular surface first. Sometimes that means delaying the procedure. Sometimes it means choosing a different surgical option. Sometimes it means discovering that the patient’s “bad vision day” is not just about prescription strength, but also about tear-film quality.
PRK and EVO ICL may enter the conversation for different reasons. PRK avoids creating a LASIK flap, but it still involves the corneal surface and requires healing. EVO ICL does not reshape the cornea with a laser. Instead, a lens is placed inside the eye to help focus light. That lens-based approach may be relevant for certain patients whose corneas or ocular surface make laser reshaping less ideal.
The practical takeaway is simple: dry eye symptoms should not be treated as a side note. They can affect comfort, healing, and the quality of vision after surgery. A good evaluation should ask about screen time, contact lens comfort, eye drops, allergy symptoms, and whether vision fluctuates throughout the day.
Those small details often explain why one procedure is more realistic than another.
High prescriptions may need more than laser reshaping
People with higher prescriptions often start with LASIK because it is the best-known option. But higher myopia can make the decision more complicated.
Laser vision correction works by reshaping the cornea. In general, the more corrections needed, the more corneal tissue may need to be treated. That does not automatically rule out LASIK, but it does make planning more dependent on corneal thickness, corneal shape, and the safety limits of the treatment.
This is one reason EVO ICL can be important for patients with moderate to high nearsightedness. The FDA describes EVO ICL as an artificial lens implanted inside the eye to correct nearsightedness, with a toric version used for nearsighted patients who also have astigmatism [5]. The device is indicated for patients ages 21 to 45 who are nearsighted, and the toric version is used for patients in that same age range who are nearsighted and also have astigmatism [5].
Unlike LASIK or PRK, EVO ICL does not remove corneal tissue to achieve the correction. The natural lens stays in place, and the implanted lens helps bend light so it focuses more accurately on the retina [5]. That difference can make EVO ICL worth discussing when a patient has a higher prescription, thin corneas, or other findings that make corneal laser treatment less suitable.
That said, EVO ICL is not simply “LASIK without the laser.” It is an intraocular procedure, meaning surgery takes place inside the eye. It has its own candidacy requirements. The FDA notes that EVO ICL should not be used in certain patients, including those who are pregnant or nursing, under age 21, have moderate to severe glaucoma, have an anterior chamber that is not the right shape for the lens, or lack an acceptable density of corneal endothelial cells [5].
That is why EVO ICL should be presented carefully: not as a shortcut, but as a different category of vision correction. For the right patient, it may offer a path that laser reshaping cannot. For another patient, LASIK or PRK may remain the better fit.
The goal is not to force every prescription into one procedure. It is to match the correction method to the anatomy.
Why candidacy testing matters before choosing a procedure
A proper refractive surgery evaluation should feel more detailed than a routine glasses prescription. That is because the question is not only “Can you see clearly with correction?” It is “Which correction method can your eyes support safely?”
Screening usually looks at several areas at once. The provider needs to know whether the prescription has been stable, whether the cornea is thick and regular enough, whether there are signs of keratoconus or other corneal disease, whether tear production is healthy, how large the pupils are in dim light, and whether the patient has medical or eye conditions that could affect healing.
The FDA checklist reflects this broader approach by asking patients to consider stable refraction, high or low refractive error, pupil size, corneal thickness, tear production, medical conditions, eye conditions, and recovery expectations before LASIK [2]. Those factors are not paperwork. They are the foundation of the recommendation.
This is also where technology and clinical judgment meet. Corneal mapping can show whether the cornea is regular or suspicious. Tear-film testing can reveal dryness that should be treated first. Measurements inside the eye can help determine whether EVO ICL is anatomically appropriate. A conversation about work, sports, screens, driving, and recovery time can shape which option feels realistic.
For readers comparing options in Greater Houston, the uploaded practice facts describe a refractive decision pathway that includes LASIK, PRK, EVO ICL, and lens-based procedures. The same approach also emphasizes dry eye optimization, corneal mapping, wavefront analysis, and candidacy screening [6].
That type of evaluation is especially relevant for patients with thin corneas, higher prescriptions, ocular surface concerns, or other factors that may make LASIK less suitable. The recommendation should be built around the patient’s measurements, eye health, and visual goals.
PRK or EVO ICL may be the better recommendation when LASIK is not ideal, but the reason should always be clear. A patient should leave the consultation understanding what was measured, what risks were considered, and why one option was favored over another.
The right answer is not always the procedure a patient knew first. It is the one supported by the exam.
References: [1] U.S. Food and Drug Administration. (2021). What is LASIK? Content current as of January 15, 2021. [2] U.S. Food and Drug Administration. (2018). LASIK surgery checklist. Content current as of July 11, 2018. [3] U.S. Food and Drug Administration. (2018). When is LASIK not for me? Content current as of July 11, 2018. [4] Semnani, F., Rayati Damavandi, A., Abdollahi, M., Sajadi, M., Sadoughi, M., & Hassanpour, K. (2025). Photorefractive keratectomy (PRK) in patients with thin corneas: A systematic review and meta-analysis of clinical outcomes and complications.Journal of Cataract & Refractive Surgery. [5] U.S. Food and Drug Administration. (2022). EVO/EVO+ Visian Implantable Collamer Lens – P030016/S035. Content current as of April 18, 2022.
